Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response—a prospective open-label study

BACKGROUND: While the frequency and importance of antipsychotic switching in patients with schizophrenia, there is insufficient evidence with regard to switching strategy. Quetiapine is one of the drugs of choice for switch because of its unique receptor profile. However, there were no data on the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Naoki, Toyomaki, Atsuhito, Honda, Minoru, Miyano, Satoru, Nitta, Nobuyuki, Sawayama, Hiroyuki, Sugawara, Yasufumi, Uemura, Keiichi, Tsukamoto, Noriko, Koyama, Tsukasa, Kusumi, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308846/
https://www.ncbi.nlm.nih.gov/pubmed/25632293
http://dx.doi.org/10.1186/s12991-014-0039-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308846/
https://www.ncbi.nlm.nih.gov/pubmed/25632293
http://dx.doi.org/10.1186/s12991-014-0039-6

Ejemplares similares